Overview
Michael Rosove is a Hematologist and an Oncologist in Los Angeles, California. Dr. Rosove is rated as an Experienced provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Polycythemia Vera, Chronic Lymphocytic Leukemia (CLL), Essential Thrombocythemia, and Richter Syndrome.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hemolytic-Uremic Syndrome.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Additional Areas of Focus
Dr. Rosove has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ilene Weitz is a Hematologist in Los Angeles, California. Dr. Weitz is rated as a Distinguished provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Autoimmune Hemolytic Anemia, Atypical Hemolytic Uremic Syndrome (aHUS), Splenectomy, and Bone Marrow Aspiration.
Hoag Clinic
Pooja Motwani is a Hematologist Oncology specialist and a Hematologist in Newport Beach, California. Dr. Motwani is rated as a Distinguished provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.
Robert Vescio is a Hematologist and an Oncologist in Tarzana, California. Dr. Vescio is rated as an Elite provider by MediFind in the treatment of Hemolytic-Uremic Syndrome. His top areas of expertise are Multiple Myeloma, Bone Tumor, Cardiac Amyloidosis, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Vescio is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Rosove isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Essential ThrombocythemiaDr. Rosove isDistinguished. Learn about Essential Thrombocythemia.
- Polycythemia VeraDr. Rosove isDistinguished. Learn about Polycythemia Vera.
- Advanced
- Adult Immune ThrombocytopeniaDr. Rosove isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Rosove isAdvanced. Learn about Agranulocytosis.
- Antiphospholipid SyndromeDr. Rosove isAdvanced. Learn about Antiphospholipid Syndrome.
- Autoimmune Hemolytic AnemiaDr. Rosove isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Castleman DiseaseDr. Rosove isAdvanced. Learn about Castleman Disease.
- Childhood Acute Myeloid LeukemiaDr. Rosove isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Experienced
- Acute Eosinophilic PneumoniaDr. Rosove isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Rosove isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Rosove isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Rosove isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.